Published in Annu Rev Pharmacol Toxicol on January 01, 1991
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology (2009) 2.31
Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A (2000) 2.22
The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect (1994) 2.16
Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc Natl Acad Sci U S A (2005) 1.82
Morbidity study of extruder personnel with potential exposure to brominated dioxins and furans. I. Results of blood monitoring and immunological tests. Br J Ind Med (1992) 1.60
Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation. Immunol Cell Biol (2013) 1.60
Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. Carcinogenesis (2008) 1.37
Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals. Environ Health Perspect (1995) 1.27
The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci (2010) 1.00
Environmental toxicology of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ Health Perspect (1993) 0.98
Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region. Toxicology (2009) 0.94
2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells. Toxicol Appl Pharmacol (2011) 0.93
Impaired cellular immune response in harbour seals (Phoca vitulina) feeding on environmentally contaminated herring. Clin Exp Immunol (1995) 0.93
Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells. Toxicol Sci (2010) 0.88
Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression. PLoS One (2012) 0.87
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos (2015) 0.86
Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes. Toxicol Sci (2011) 0.85
Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis. Toxicology (2016) 0.80
Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells. Toxicol Appl Pharmacol (2016) 0.76
The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Toxicol Sci (2015) 0.75
2,3,7,8-tetrachlorodibenzo-p-dioxin slows the progression of experimental cutaneous Leishmaniasis in susceptible BALB/c and SCID mice. PLoS One (2013) 0.75
The Influence of Human Interindividual Variability on the Low-Dose Region of Dose-Response Curve Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Primary B Cells. Toxicol Sci (2016) 0.75
SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol (2016) 0.75
Quantitative Determination of Carbohydrates With Dreywood's Anthrone Reagent. Science (1948) 27.02
Optimal timing of operation for bleeding peptic ulcer: prospective randomised trial. Br Med J (Clin Res Ed) (1984) 3.82
Is the emergency ambulance service abused? Br Med J (1980) 3.62
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol (2001) 2.43
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics (2001) 2.43
Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology (1999) 2.39
Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. Br J Surg (1994) 2.18
Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke (2000) 2.14
The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. Am J Epidemiol (1967) 2.11
Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics. Am J Epidemiol (1973) 1.84
A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke (2009) 1.76
Short-course cimetidine and survival with colorectal cancer. Lancet (1995) 1.73
Cryotherapy for liver metastases: a new approach. Br J Surg (1989) 1.73
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol (2000) 1.72
Albendazole--objective evidence of response in human hydatid disease. JAMA (1985) 1.67
Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641. J Gen Virol (1999) 1.62
The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood (1995) 1.61
Biochemical typing of scrapie strains. Nature (1997) 1.59
Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant (2009) 1.59
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem (2001) 1.53
The management of hydatid disease of the liver: Part 1. Trop Doct (1996) 1.52
Pilot study--cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer (1997) 1.50
Clinical and radiographic features of simple and hydatid cysts of the liver. Br J Surg (1986) 1.47
Management of patients after mastectomy. Br Med J (Clin Res Ed) (1981) 1.46
Use of sublingual antigen in diagnosis and treatment of food allergy. Ann Allergy (1969) 1.46
Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Acad Emerg Med (1998) 1.46
The initial care of newborn infants and subsequent hay fever. Allergy (2000) 1.46
Beta-endorphin in cerebrospinal fluid and serum after severe head injury. Neurosurgery (1990) 1.42
Development of orphan vaccines: an industry perspective. Emerg Infect Dis (2000) 1.41
Prehospital and in-hospital delays in acute stroke care. Neuroepidemiology (2001) 1.40
Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. Br J Surg (1992) 1.39
Non-cytotoxic control of colorectal cancer. J R Coll Surg Edinb (1997) 1.38
WHO position paper on oral (sublingual) immunotherapy. Ann Allergy Asthma Immunol (1999) 1.38
Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol (1986) 1.36
Altitude and ischemic heart disease in tricultural New Mexico: an example of confounding. Am J Epidemiol (1979) 1.30
Combined chemotherapy and surgery for hydatid bone disease. J Bone Joint Surg Br (1987) 1.30
A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb (1998) 1.26
Albendazole treatment of pulmonary hydatid cysts in naturally infected sheep: a study with relevance to the treatment of hydatid cysts in man. Thorax (1985) 1.26
Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest (1985) 1.26
A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology (1991) 1.25
World survey on the complications of hepatic and prostate cryotherapy. World J Surg (1999) 1.25
Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg (1988) 1.24
Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res (1991) 1.22
Rapid recovery of Echinococcus granulosus following 'successful' albendazole therapy in a gerbil model. J Helminthol (1989) 1.21
Multiple low-level antibiotic resistance in Aeromonas salmonicida. Antimicrob Agents Chemother (1986) 1.20
The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer (1989) 1.20
Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity (1999) 1.19
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg (2006) 1.19
The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin. Int J Cancer (1989) 1.19
Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol (2010) 1.18
Lactate extraction during net lactate release in legs of humans during exercise. J Appl Physiol (1985) (1986) 1.17
The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer cell lines. Cancer (1989) 1.17
Albendazole in hydatid disease. Br Med J (Clin Res Ed) (1983) 1.17
Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry (1991) 1.16
Gallbladder disease and gallbladder cancer among American Indians in tricultural New Mexico. Cancer (1978) 1.16
Emergency department management of patients with seizures: a multicenter study. Acad Emerg Med (2001) 1.15
Combination chemotherapy is more effective in postspillage prophylaxis for hydatid disease than either albendazole or praziquantel alone. Br J Surg (1989) 1.15
Effects of teaching resourcefulness skills to elders. Aging Ment Health (2006) 1.15
Laser Doppler flowmetry in evaluation of cutaneous wound blood flow using various suturing techniques. Ann Surg (1992) 1.15
Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro. Trans R Soc Trop Med Hyg (1986) 1.14
Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease. Br Med J (Clin Res Ed) (1982) 1.14
Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant (2009) 1.13
Two cases of spontaneous liver rupture and literature review. HPB Surg (1996) 1.11
Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I. Br J Cancer (1991) 1.09
Reflux versus dysphagia: an objective evaluation of the Angelchik prosthesis. Br J Surg (1985) 1.09
Congestive heart failure: who should provide care? Ann Intern Med (2000) 1.09
Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol (1999) 1.08
Parasitic causes of obstructive jaundice. Ann Trop Med Parasitol (1989) 1.08
Azithromycin clinical pharmacokinetics. Clin Pharmacokinet (1993) 1.08
Intracellular gastrin in human gastrointestinal tumor cells. J Natl Cancer Inst (1991) 1.08
Complexes of liver alcohol dehydrogenase. Further studies on the rate of inactivation. Eur J Biochem (1970) 1.07
Upward fixation of the patella in cattle: 38 cases (1984-1990). J Am Vet Med Assoc (1993) 1.06
Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer (1983) 1.06
Accuracy of identification of early gastric cancer. Br J Surg (1987) 1.06
Choledochoscopy via the cystic duct: evaluation of a new ultrathin disposable choledochoscope. Ann R Coll Surg Engl (1989) 1.06
Gas exchange and control of breathing in reptiles. Physiol Rev (1983) 1.05
Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol (1998) 1.05
Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol (2001) 1.05
Penetration of albendazole sulphoxide into hydatid cysts. Gut (1987) 1.05
Tetracyclines: drugs with huge therapeutic potential. Mini Rev Med Chem (2012) 1.05
Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut (1994) 1.05
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett (2001) 1.04
Abdominal hydatid disease: computed tomographic and ultrasound changes during albendazole therapy. Clin Radiol (1984) 1.03
Venous stasis during laparoscopic cholecystectomy. Surg Laparosc Endosc (1994) 1.03
Human xylazine overdose: a comparative review with clonidine, phenothiazines, and tricyclic antidepressants. Clin Toxicol (1981) 1.02
Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg (1991) 1.02
New complications associated with the Angelchik prosthesis. Thorax (1986) 1.01
Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg (1998) 0.99
Electrohydraulic lithotripsy of gall stones--in vitro and animal studies. Gut (1987) 0.98
Can albendazole reduce the risk of implantation of spilled protoscoleces? An animal study. Trans R Soc Trop Med Hyg (1986) 0.98
The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV). Infection (1999) 0.98
The lysines in liver alcohol dehydrogenase. Chemical modification with pyridoxal 5'-phosphate and methyl picolinimidate. Eur J Biochem (1972) 0.97
Operative choledochoscopy via the cystic duct: a pilot study with an ultra-thin fibreoptic endoscope. Br J Surg (1987) 0.97
Protoscolicidal effect of praziquantel--in-vitro and electron microscopical studies on Echinococcus granulosus. J Antimicrob Chemother (1986) 0.97
The critical role of vascular endothelial growth factor in tumor angiogenesis. Curr Cancer Drug Targets (2012) 0.97
H2-antagonists in the treatment of colon and breast cancer. Semin Cancer Biol (2000) 0.97
Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg (2010) 0.96